Showing results (241-250 of 451) with videos related to

Sort By:
Pageof 46
Journal of the American Society of Nephrology : JASN|May 17, 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-AnalysisAmarnath Marthi, Killian Donovan, Richard Haynes, et al.
European Heart Journal|March 21, 2025
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction modelsEmanuele Di Angelantonio, Lisa Pennells, Magdy Abdelhamid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project TeamHelen Donnelly, Demissie Alemayehu, Radu Botgros, et al.
The American Journal of Cardiology|August 29, 2017
Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes MellitusNaveed Sattar, Peter P Toth, Dirk J Blom, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Circulation|March 7, 2022
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular DiseaseCiaran N Kohli-Lynch, James Lewsey, Kathleen A Boyd, et al.
JACC. Heart Failure|August 8, 2015
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical TrialsChristopher J Rush, Ross T Campbell, Pardeep S Jhund, et al.
Respiratory Medicine|August 15, 2009
A simple and portable breathing circuit designed for ventilatory muscle endurance training (VMET)Dahlia Y Balaban, Rosemary Regan, Alexandra Mardimae, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2015
Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment?Paul Welsh, Carole Hart, Olia Papacosta, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
Pageof 46